141 related articles for article (PubMed ID: 17086357)
1. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
2. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
Badve SS; Baehner FL; Gray RP; Childs BH; Maddala T; Liu ML; Rowley SC; Shak S; Perez EA; Shulman LJ; Martino S; Davidson NE; Sledge GW; Goldstein LJ; Sparano JA
J Clin Oncol; 2008 May; 26(15):2473-81. PubMed ID: 18487567
[TBL] [Abstract][Full Text] [Related]
3. Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities.
Guan L; Xu G
World J Surg Oncol; 2016 May; 14(1):153. PubMed ID: 27230124
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
[No Abstract] [Full Text] [Related]
5. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.
Kleer CG; van Golen KL; Merajver SD
Breast Cancer Res; 2000; 2(6):423-9. PubMed ID: 11250736
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression.
Sawicka-Gutaj N; Waligórska-Stachura J; Andrusiewicz M; Biczysko M; Sowiński J; Skrobisz J; Ruchała M
Tumour Biol; 2015 Sep; 36(10):7859-63. PubMed ID: 25946974
[TBL] [Abstract][Full Text] [Related]
7. The detection of circulating breast cancer cells in blood.
Gilbey AM; Burnett D; Coleman RE; Holen I
J Clin Pathol; 2004 Sep; 57(9):903-11. PubMed ID: 15333648
[TBL] [Abstract][Full Text] [Related]
8. Mesorectum localization as a special kind of rectal metastasis from breast cancer.
Xue F; Liu ZL; Zhang Q; Kong XN; Liu WZ
World J Gastroenterol; 2015 Apr; 21(14):4408-12. PubMed ID: 25892895
[TBL] [Abstract][Full Text] [Related]
9. Beta class II tubulin predominates in normal and tumor breast tissues.
Dozier JH; Hiser L; Davis JA; Thomas NS; Tucci MA; Benghuzzi HA; Frankfurter A; Correia JJ; Lobert S
Breast Cancer Res; 2003; 5(5):R157-69. PubMed ID: 12927047
[TBL] [Abstract][Full Text] [Related]
10. Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer.
Ascolani G; Occhipinti A; Liò P
PLoS Comput Biol; 2015 May; 11(5):e1004199. PubMed ID: 25978366
[TBL] [Abstract][Full Text] [Related]
11. Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.
Hayashi N; Manyam GC; Gonzalez-Angulo AM; Niikura N; Yamauchi H; Nakamura S; Hortobágyi GN; Baggerly KA; Ueno NT
Oncologist; 2014 Sep; 19(9):909-14. PubMed ID: 25117064
[TBL] [Abstract][Full Text] [Related]
12. Dual FRET molecular beacons for mRNA detection in living cells.
Santangelo PJ; Nix B; Tsourkas A; Bao G
Nucleic Acids Res; 2004 Apr; 32(6):e57. PubMed ID: 15084672
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer in Younger and Older Women: A Comparison of Clinicopathological Traits.
Jahan S; Rahman MM; Biswas SK; Hossain ATM; Saha B; Haque SMA
Mymensingh Med J; 2024 Apr; 33(2):433-439. PubMed ID: 38557522
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
Ruiz-Garcia E; Scott V; Machavoine C; Bidart JM; Lacroix L; Delaloge S; Andre F
Br J Cancer; 2010 Feb; 102(3):462-8. PubMed ID: 20068563
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood.
Martin KJ; Graner E; Li Y; Price LM; Kritzman BM; Fournier MV; Rhei E; Pardee AB
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2646-51. PubMed ID: 11226293
[TBL] [Abstract][Full Text] [Related]
16. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
17. New insights into the correlations between circulating tumor cells and target organ metastasis.
Zhan Q; Liu B; Situ X; Luo Y; Fu T; Wang Y; Xie Z; Ren L; Zhu Y; He W; Ke Z
Signal Transduct Target Ther; 2023 Dec; 8(1):465. PubMed ID: 38129401
[TBL] [Abstract][Full Text] [Related]
18. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions.
Ugonabo O; Udoh US; Rajan PK; Reeves H; Arcand C; Nakafuku Y; Joshi T; Finley R; Pierre SV; Sanabria JR
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759769
[TBL] [Abstract][Full Text] [Related]
19. Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants.
Vasilatis DM; Lucchesi CA; Ghosh PM
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189720
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment.
Chaddha M; Rai H; Gupta R; Thakral D
Front Genet; 2023; 14():1138625. PubMed ID: 37091783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
